Weiss Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,080
Closed -$821K 664
2026
Q1
$821K Buy
+13,080
New +$1.05M 0.01% 354
2024
Q4
Sell
-56,027
Closed -$4.7M 652
2024
Q3
$4.7M Buy
+56,027
New +$4.42M 0.1% 211
2024
Q1
Sell
-34,117
Closed -$1.97M 337
2023
Q4
$1.97M Buy
+34,117
New +$1.82M 0.09% 104
2023
Q2
Sell
-127,914
Closed -$6.4M 235
2023
Q1
$6.4M Buy
+127,914
New +$6.03M 0.41% 65
2021
Q3
Sell
-54,242
Closed -$2.32M 510
2021
Q2
$2.32M Buy
+54,242
New +$2.28M 0.06% 285
2021
Q1
Sell
-211,835
Closed -$7.62M 504
2020
Q4
$7.62M Buy
+211,835
New +$7.63M 0.34% 86

Other funds holding BSX

Weiss Asset Management's BSX Position: Q2 2026 in Review

Weiss Asset Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 13,080 shares — an estimated $821K sold.

Weiss Asset Management first reported a position in BSX in Q4 2020 and held it in 6 quarters. The position peaked at $7.62M in Q4 2020. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Weiss Asset Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Weiss Asset Management sold 13,080 Boston Scientific shares in Q2 2026, an estimated $821K.
  • Weiss Asset Management first reported a position in Boston Scientific in Q4 2020 and held it in 6 quarters.
  • Weiss Asset Management's Boston Scientific position peaked at $7.62M in Q4 2020.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Weiss Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.